<DOC>
	<DOCNO>NCT02866565</DOCNO>
	<brief_summary>Diabetic foot ulcer ( DFU ) major complication lead cause hospitalization among people diabetes mellitus . It occur 15 % patient diabetes precedes 84 % low leg amputation . Despite many therapeutic advance past decade , include dressing ( hydrocolloid , alginate , skin substitute ) growth factor , heal rate DFU remain low . Mechanisms faulty wound heal diabetic patient complex , related intrinsic extrinsic factor . The main reason impair heal appear : 1/exhaustion local cell population promote wound healing ; 2/excessive production matrix metalloproteases ( MMPs ) couple reduced expression tissue inhibitor MMPs ; 3/impaired neovascularisation couple reduced number endothelial progenitor cell impairment functioning . These imbalance may result excessive degradation extracellular matrix component , well inappropriate local inflammatory response . Adipose-derived stroma vascular fraction provide rich easily accessible source autologous cell regenerative medicine application . Il contain multipotent stem cell progenitor call adipose-derived regenerative cell ( ADRCs ) able stimulate wound heal . There attract wound site supplement wound bed similar cell type , secrete numerous growth factor cytokine , increase macrophage recruitment , enhance granulation tissue , improve vascularisation . The reparative capability couple good safety ADRCs illustrate study treat severe irreversible radiation-induced lesion , study treat sclerodactyly patient diffuse scleroderma . Numerous case report show heal refractory wound follow treatment autologous ADRCs also report . Based previous report , present study aim assess efficacy tolerance injection ADRCs local treatment neuropathic neuro-ischemic DFU .</brief_summary>
	<brief_title>Assessment Efficacy Tolerance Sub-cutaneous Re-injection Autologous Adipose-derived REGEnerative Cells Local Treatment Neuropathic Diabetic Foot ulcERs</brief_title>
	<detailed_description />
	<mesh_term>Diabetic Foot</mesh_term>
	<mesh_term>Foot Ulcer</mesh_term>
	<criteria>Patient old 18 Patient type 1 2 diabetes mellitus HbA1C level &lt; 10 % Patient diagnosis neuropathic neuroischemic DFU Grade 1 2 ulcer Wagner scale Ulcer surface area comprise 1 cm2 15 cm2 day 0 Patient present minimum 4 week current investigator 's care include adequate wound debridement offload SemmesWeinstein monofilament test indicate neuropathy DFU locate toe lateral , dorsal surface forefoot heel Pregnant likely become pregnant breast feed woman Critical ischemia target limb , define pain rest ankle systolic pressure &lt; 50 mm Hg , toe systolic pressure &lt; 30 mm Hg Surgery surgical revascularisation &lt; 2months Decrease increase ulcer size 30 % within 2wk runin period DFU clinically infect defined IDSA/IWGDF criterion , osteomyelitis confirm MRI , evidence infection present Dossier LIC15150005 REGENDER Déposé le 09/03/2015 15:22:11 par M. Patrice DARMON Appel LIC152015 Page 3 sur 6 Patient bear offload method Patient active neoplasm</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>